ConductScience.org, home

Paper3530643

Reduction of nocturnal asthma by an inhaled anticholinergic drug.

Coe CI and 1 other. Chest, 1986. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. Reduction of nocturnal asthma by an inhaled anticholinergic drug. Papers, record 3530643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3530643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reduction of nocturnal asthma by an inhaled anticholinergic drug.
PubMed
Journal
Chest
PubMed
Year
1986
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
3.37
iCite
Revised in PubMed
2019-05-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Coe CIC I
2Barnes PJP J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AsthmaMajor topic
ParasympatholyticsMajor topic
Scopolamine DerivativesMajor topic
Administration, Inhalation
Adolescent
Adult
Aged
Circadian Rhythm
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Middle Aged
Peak Expiratory Flow Rate
Random Allocation

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
33204116Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry.J Asthma Allergy2020https://conductscience.org/library/papers/33204116PubMed
32026248The Role of the Body Clock in Asthma and COPD: Implication for Treatment.Pulm Ther2018https://conductscience.org/library/papers/32026248PubMed
21229079Treatment of Difficult Asthma: What do you do when asthma doesn't respond to therapy?Can Fam Physician1991https://conductscience.org/library/papers/21229079PubMed
19317386Obstructive sleep apnea syndrome and asthma: what are the links?J Clin Sleep Med2009https://conductscience.org/library/papers/19317386PubMed
18044064The development of anticholinergics in the management of COPD.Int J Chron Obstruct Pulmon Dis2007https://conductscience.org/library/papers/18044064PubMed
15683618Nocturnal asthma: underlying mechanisms and treatment.Curr Allergy Asthma Rep2005https://conductscience.org/library/papers/15683618PubMed
15266477Anticholinergic agents for chronic asthma in adults.Cochrane Database Syst Rev2004https://conductscience.org/library/papers/15266477PubMed
14514937Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.Thorax2003https://conductscience.org/library/papers/14514937PubMed
14514934Underdiagnosed asthma in South Australia.Thorax2003https://conductscience.org/library/papers/14514934PubMed
10385241Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways.Br J Pharmacol1999https://conductscience.org/library/papers/10385241PubMed
9470077Effects of inhaled salmeterol and salbutamol (albuterol) on morning dips compared in intensive care patients recovering from an acute severe asthma attack.Intensive Care Med1997https://conductscience.org/library/papers/9470077PubMed
8016790Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.Thorax1994https://conductscience.org/library/papers/8016790PubMed
7957513Dose-response study of oxitropium bromide inhaled as a nebulised solution.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/7957513PubMed
7715253Obstructive sleep apnea syndrome and bronchial hyperreactivity.Lung1995https://conductscience.org/library/papers/7715253PubMed
3132275Parasympathetic nervous system in nocturnal asthma.Br Med J (Clin Res Ed)1988https://conductscience.org/library/papers/3132275PubMed
3074291Comparison of the effect of oxitropium bromide and of slow-release theophylline on nocturnal asthma.Postgrad Med J1988https://conductscience.org/library/papers/3074291PubMed
2973665Is nocturnal asthma caused by changes in airway cholinergic activity?Thorax1988https://conductscience.org/library/papers/2973665PubMed
2772857Posture and nocturnal asthma.Thorax1989https://conductscience.org/library/papers/2772857PubMed
2650010Muscarinic receptor subtypes: implications for lung disease.Thorax1989https://conductscience.org/library/papers/2650010PubMed
1980220Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.BMJ1990https://conductscience.org/library/papers/1980220PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3530643

GET https://conductscience.org/api/papers/v1/3530643/cited_by?page=2